Regulatory challenges for refined nicotine products

Affiliations

¹ Department of Pulmonary and Critical Care, Georgetown University Medical Center, 3800 Reservoir Road, NW, 4 North Main Hospital, Washington, DC 20007, USA; Department of Health, Behavior and Society, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; MeYou Health LLC, Boston, MA, USA; Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundation, Washington, DC, USA. Electronic address: nkc4@georgetown.edu.
² Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundation, Washington, DC, USA.

Nathan K Cobb et al. Lancet Respir Med. 2013 Aug.

. 2013 Aug;1(6):431-3.

doi: 10.1016/S2213-2600(13)70160-7. Epub 2013 Jul 23.

¹ Department of Pulmonary and Critical Care, Georgetown University Medical Center, 3800 Reservoir Road, NW, 4 North Main Hospital, Washington, DC 20007, USA; Department of Health, Behavior and Society, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; MeYou Health LLC, Boston, MA, USA; Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundation, Washington, DC, USA. Electronic address: nkc4@georgetown.edu.
² Schroeder Institute for Tobacco Research and Policy Studies, American Legacy Foundation, Washington, DC, USA.

No abstract available

Comment in

Regulation of e-cigarettes: the users' perspective.
Polosa R, Caponnetto P. Polosa R, et al. Lancet Respir Med. 2013 Sep;1(7):e26. doi: 10.1016/S2213-2600(13)70175-9. Epub 2013 Sep 3. Lancet Respir Med. 2013. PMID: 24461619 No abstract available.